Sumitomo Pharma (OTCMKTS:DNPUF) Stock Price Down 8.1% – Here’s What Happened

Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUFGet Free Report) shares fell 8.1% during trading on Friday . The stock traded as low as $10.50 and last traded at $10.50. 118 shares changed hands during trading, a decline of 92% from the average session volume of 1,530 shares. The stock had previously closed at $11.4250.

Sumitomo Pharma Price Performance

The business’s 50 day moving average is $12.71 and its 200-day moving average is $13.70.

About Sumitomo Pharma

(Get Free Report)

Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.

The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.

Featured Articles

Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.